期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌标志物对评估预后的意义 被引量：1

The Prognostic Significance of Tumor Markers for Breast Cancer
下载PDF
导出
摘要 乳腺癌是妇女常见恶性肿瘤,筛选出高危患者进行相应的治疗,会明显提高疗效 ,但目前应用的标志物尚不能满足临床的需要,人们一直在寻找其它更好的指标,本文介绍近年来在这方面的新进展。 Breast cancer is a common malignant tumor in women.To screen out the patients with the high risk of metastasis and offer appropriate treatment for them will improve curative effect.However at the present time the tumor markers can not meet the needs of clinical work,to search the better markers is necessary.The article will introduce the new progress about this field in the past few years.
作者 张涛
机构地区 中国医学科学院中国协和医科大学肿瘤医院
出处 《肿瘤学杂志》 CAS 2002年第6期343-346,共4页 Journal of Chinese Oncology
关键词 乳腺肿瘤 预后 肿瘤标志物 breast neoplasms prognosis tumor marker
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献20

  • 1Hayes DF, Yamauchi H, Broadwater G, et al. Circulating Her 2/erbB 2/c neu(Her 2) extracellular domain as a prognostic factor in patients with metastatic breast cancer :cancer and leukemia group B study 8662[J]. Clin Cancer Res, 2001,7(9):2703- 2711.
  • 2Tanner M, Jarvinen P, Isola J. Amplification of Her 2/neu and topoismerase Ⅱ in primary and metastatic breast cancer[J]. Cancer Res, 2001,61(14):5345- 5348.
  • 3Yamauchi H, Stearns V, Hayes DF. When is a tumor marker ready for prime time ? A case study of C erbB 2 as a predictive factor in breast cancer[J]. J Clin Oncol, 2001,19:2334- 2356.
  • 4Hayes DF, Trock B, Harris A. Assessing the clinical impact of prognostic factors:when is " stastistically significant " clinically useful?[J].Breast Cancer Res Treat , 1998,52(3):305- 315.
  • 5Gillesby BE,Zacharewski TR. PS2(TFF1) levels in human breast cancer tumor samples:correlation with clincial and histological prognostic markers[J]. Breast Cancer Res Treat, 1999,56(3):253- 265.
  • 6Elledge RM, Green S, Paugh R, et al. Estrogen receptor(ER) and progesterone erceptor(PgR), by ligand binding assay compared with ER, PgR and PS2, by immunohischemistry in predicting response to tamoxifen in mestastatic breast cancer: a southwest oncology group study [J]. Int J Cancer , 2000,89(2):111- 117.
  • 7Chen H, Fering DG, Rudland PS, et al. Binding to intracellular targets of the metastasis inducing protein, S100A4(P9Ka) [J]. Biochem Biophys Res Commun,2001,286(5):1212- 1217.
  • 8Rudland PS, Platt HA, Renshaw C, et al.Prognostic significance of the metastasis inducing protein S100A4(P9KA) in human breast cancer[J]. Cancer Res, 2000,60(6):1595- 1603.
  • 9Platt Higgins AM, Renshaw CA, West CR, et al. Comparison of the metastasis- inducing protein S100A4(P9Ka) with other prognostic markers in human breast cancer[J]. Int J Cancer, 2000,89(2):198- 208.
  • 10Foekens JA, Peters HA, Grebenchtchikov N, et al. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer[J]. Cancer Res , 2001,61(14):5407- 5414.

同被引文献4

  • 1Jukkola A, Bloigu R, Soini Y, et al. c-erbB-2 positivity is a factor for poor prognosis in breast cancer and poor response to hormanal or chemotherapy treatment in advanced disease[J]. Eur J Cancer, 2001, 37(3):347-354.
  • 2Elledge R M, Green S, Paugh R, et al. Estrogen receptor(ER) and progesterone receptor (PgR), by ligand binding assay compared with ER, PgR and PS2, by immunohis to chemistry in predicting response to tamoxifen in mestastatic breast cancer: a southwest oncology group study [J]. Int J Cancer, 2000, 89(2):111.
  • 3阚秀,薛卫成.乳腺癌中PS_2基因与雌激素及孕激素受体[J].中华肿瘤杂志,1998,20(3):237-239. 被引量：23
  • 4许炳基,倪灿荣,范淼.乳腺癌中nm23与C-erbB-2、ER、PR的表达及预后相关性研究[J].诊断病理学杂志,1999,6(3):171-171. 被引量：8

引证文献1

二级引证文献2

肿瘤学杂志
2002年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部